Macrogen Europe

Biotechnology Research, Medical and pharmaceutical research, Research and testing · 11 Employees
Phone Number: ngs@macrogen-europe.com
Email Address: ngs@macrogen-europe.com
  • Overview
  • Employees
Access 38 Verified Employees Profiles for Macrogen EuropeUnlock Free Contacts Now
About
At Macrogen Europe, every sequence counts. We provide fast and reliable Sanger sequencing, next generation sequencing (NGS) and bioinformatics services to scientists in Europe and Africa. Committed to speed, accuracy and scientific excellence, we work in close partnership with academic and clinical researchers – as well as the biotech industry – to realize the unlimited potential of the genome. Contact us now at info@macrogen-europe.com to accelerate your genomics research – we’d love to hear from you!
Year Founded
2008
Social Media
Linkedin
Industry
Biotechnology Research, Medical and pharmaceutical research, Research and testing, IT, Internet, R&D, Food industry research and development, Holding companies and groups of companies, Financial and insurance services, Business Services
HQ Location
Meibergdreef 57 Amsterdam, North Holland 1105 BA, NL
Keywords
Next Generation SequencingSanger SequencingDNA SequencingBioinformaticsGeneticsand Genomics
Location
  • Meibergdreef 57 Amsterdam, North Holland 1105 BA, NL

Email Formats

Sign up for free credits and discover verified email addresses of Macrogen Europe
FormatExamples
first + last
andywarhol@macrogen-europe.com
first_initial + last
awarhol@macrogen-europe.com
first + last_initial
andyw@macrogen-europe.com
first
andy@macrogen-europe.com
last
warhol@macrogen-europe.com
Get Verified Emails for 38 Macrogen Europe Employees

Frequently Asked Questions

Learn More about Macrogen Europe
Key Contacts

Similar Companies

Biotechnology Research, Medical and pharmaceutical research, Research and testing

Get key business info for Macrogen Europe and other 100M companies. Start your seach.

No Credit Card Needed. By signing up, you understand and agree to Futern's Terms and Policy.